REPORT ID 4942

Global Diabetic Peripheral Neuropathy Treatment Market Research Report 2017

Publish Date
20-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the global Diabetic Peripheral Neuropathy Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Diabetic Peripheral Neuropathy Treatment in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Diabetic Peripheral Neuropathy Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Achelios Therapeutics Inc
    Celgene Corp
    Commence Bio Inc
    Grunenthal GmbH
    Immune Pharmaceuticals Inc
    KPI Therapeutics Inc
    Medifron DBT Co Ltd
    Mitsubishi Tanabe Pharma Corp
    Novaremed Ltd
    Reata Pharmaceuticals Inc
    Relief Therapeutics Holding AG
    ViroMed Co Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antimunocel
    ASP-8477
    BNV-222
    Capsaicin
    CBX-129801
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Diabetic Peripheral Neuropathy Treatment Market Research Report 2017
1 Diabetic Peripheral Neuropathy Treatment Market Overview
    1.1 Product Overview and Scope of Diabetic Peripheral Neuropathy Treatment
    1.2 Diabetic Peripheral Neuropathy Treatment Segment by Type (Product Category)
        1.2.1 Global Diabetic Peripheral Neuropathy Treatment Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Diabetic Peripheral Neuropathy Treatment Production Market Share by Type (Product Category) in 2016
        1.2.3 Antimunocel
        1.2.4 ASP-8477
        1.2.5 BNV-222
        1.2.6 Capsaicin
        1.2.7 CBX-129801
        1.2.8 Others
    1.3 Global Diabetic Peripheral Neuropathy Treatment Segment by Application
        1.3.1 Diabetic Peripheral Neuropathy Treatment Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Diabetic Peripheral Neuropathy Treatment Market by Region (2012-2022)
        1.4.1 Global Diabetic Peripheral Neuropathy Treatment Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Diabetic Peripheral Neuropathy Treatment (2012-2022)
        1.5.1 Global Diabetic Peripheral Neuropathy Treatment Revenue Status and Outlook (2012-2022)
        1.5.2 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production Status and Outlook (2012-2022)

2 Global Diabetic Peripheral Neuropathy Treatment Market Competition by Manufacturers
    2.1 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Diabetic Peripheral Neuropathy Treatment Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Diabetic Peripheral Neuropathy Treatment Production and Share by Manufacturers (2012-2017)
    2.2 Global Diabetic Peripheral Neuropathy Treatment Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Diabetic Peripheral Neuropathy Treatment Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Diabetic Peripheral Neuropathy Treatment Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Diabetic Peripheral Neuropathy Treatment Market Competitive Situation and Trends
        2.5.1 Diabetic Peripheral Neuropathy Treatment Market Concentration Rate
        2.5.2 Diabetic Peripheral Neuropathy Treatment Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Diabetic Peripheral Neuropathy Treatment Capacity and Market Share by Region (2012-2017)
    3.2 Global Diabetic Peripheral Neuropathy Treatment Production and Market Share by Region (2012-2017)
    3.3 Global Diabetic Peripheral Neuropathy Treatment Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Diabetic Peripheral Neuropathy Treatment Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Diabetic Peripheral Neuropathy Treatment Consumption by Region (2012-2017)
    4.2 North America Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)
    4.4 China Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)
    4.7 India Diabetic Peripheral Neuropathy Treatment Production, Consumption, Export, Import (2012-2017)

5 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue (Value), Price Trend by Type
    5.1 Global Diabetic Peripheral Neuropathy Treatment Production and Market Share by Type (2012-2017)
    5.2 Global Diabetic Peripheral Neuropathy Treatment Revenue and Market Share by Type (2012-2017)
    5.3 Global Diabetic Peripheral Neuropathy Treatment Price by Type (2012-2017)
    5.4 Global Diabetic Peripheral Neuropathy Treatment Production Growth by Type (2012-2017)

6 Global Diabetic Peripheral Neuropathy Treatment Market Analysis by Application
    6.1 Global Diabetic Peripheral Neuropathy Treatment Consumption and Market Share by Application (2012-2017)
    6.2 Global Diabetic Peripheral Neuropathy Treatment Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Diabetic Peripheral Neuropathy Treatment Manufacturers Profiles/Analysis
    7.1 Achelios Therapeutics Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Celgene Corp
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Commence Bio Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Grunenthal GmbH
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Immune Pharmaceuticals Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 KPI Therapeutics Inc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Medifron DBT Co Ltd
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Mitsubishi Tanabe Pharma Corp
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Novaremed Ltd
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Reata Pharmaceuticals Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Diabetic Peripheral Neuropathy Treatment Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Relief Therapeutics Holding AG
    7.12 ViroMed Co Ltd

8 Diabetic Peripheral Neuropathy Treatment Manufacturing Cost Analysis
    8.1 Diabetic Peripheral Neuropathy Treatment Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Diabetic Peripheral Neuropathy Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Diabetic Peripheral Neuropathy Treatment Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Diabetic Peripheral Neuropathy Treatment Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Diabetic Peripheral Neuropathy Treatment Market Forecast (2017-2022)
    12.1 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Diabetic Peripheral Neuropathy Treatment Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Diabetic Peripheral Neuropathy Treatment Price and Trend Forecast (2017-2022)
    12.2 Global Diabetic Peripheral Neuropathy Treatment Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Diabetic Peripheral Neuropathy Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer